MEDPMedpace Holdings, Inc.

$612.15+23% 1Y

Is it growing?

Good

Growing: revenue growing +25% year on year and earnings up +27% year on year.

2 good, 1 neutral
Revenue trend+25% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +22% a year.

Earnings trend+27% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction−0.4 points operating

Trailing-twelve-month operating margin, 21.0% now against 21.4% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbetter than 87% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is MEDP growing?

Medpace Holdings, Inc. has grown revenue 18% a year over three years and 22% a year over five, with earnings per share compounding at 27%.

+18%

Revenue growth, 3-year annual rate · Diagnostics & Research median +8.4% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate
+22%

Revenue growth, 5-year rate · +18% over three · growth has slowed since the five-year average

Earnings per share, 3-year rate
+27%

Earnings per share, 3-year rate · revenue +18% · earnings outgrew revenue: margins or the share count worked for shareholders

Years of annual history on file
11

Years of annual history on file · FY2015 to FY2025, as filed

Details›
Revenue FY2021
$1.14B
Revenue FY2022
$1.46B
Revenue FY2023
$1.89B
Revenue FY2024
$2.11B
Revenue FY2025
$2.53B

Annual income statements as filed with the SEC.